Clinical Trials Browser

Hypoxia, Head and Neck Neoplasms

NCT06108089 2024-08-12

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Recruiting

20 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT04995185 2024-05-16

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Phase NA Completed

9 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Hypoxia, Nasopharyngeal Neoplasms

NCT01827709 2023-04-03

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Phase NA Terminated

11 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Head and Neck Neoplasms

NCT03547388 2020-05-05

GKH-TMM

Phase 1 Completed

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hyperthermia, Hypoxia, Head and Neck Neoplasms, Recurrence

NCT02976883 2019-01-11

OXYPET

Phase 2 Completed

8 enrolled

Head & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Lung Neoplasms

NCT01347281 2017-01-30

PET With [18F]HX4 in Head and Neck Cancer

Phase NA Completed

23 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT02414048 2016-06-17

Hypoxia Analysis in Head and/or Neck Cancer

Phase 2 Unknown

10 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT01212354 2016-02-09

Escalox

Phase 3 Unknown

270 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

NCT00159978 2015-05-07

Validation of 18F-MISO-PET and 18F-FLT-PET

Terminated

21 enrolled

Head & Neck

Hypoxia, Head and Neck Neoplasms

Clinical Trials

FARHEAD

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

GKH-TMM

OXYPET

PET With [18F]HX4 in Head and Neck Cancer

Hypoxia Analysis in Head and/or Neck Cancer

Escalox

Validation of 18F-MISO-PET and 18F-FLT-PET